Trial ID or NCT#

NCT03030599

Status

RECRUITING

Purpose

This is a double-blind, placebo-controlled, randomized-withdrawal, multicenter study of the efficacy and safety of JZP-258.

Official Title

A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Eligibility Criteria

Ages Eligible for Study: 18 Years to 70 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Emmanuel Mignot, MD, PhD
Sleep specialist
Craig Reynolds Professor of Sleep Medicine

Contact us to find out if this trial is right for you.

CONTACT

SPECTRUM